Literature DB >> 10098871

Carboxyfullerene prevents iron-induced oxidative stress in rat brain.

A M Lin1, B Y Chyi, S D Wang, H H Yu, P P Kanakamma, T Y Luh, C K Chou, L T Ho.   

Abstract

Carboxyfullerene, a water-soluble carboxylic acid derivative of a fullerene, was investigated as a protective agent against iron-induced oxidative stress in the nigrostriatal dopaminergic system of anesthetized rats. Intranigral infusion of exclusive carboxyfullerene did not increase lipid peroxidation in substantia nigra or deplete dopamine content in striatum. Infusion of ferrous citrate (iron II) induced degeneration of the nigrostriatal dopaminergic system. An increase in lipid peroxidation in substantia nigra as well as decreases in K+-evoked dopamine overflow and dopamine content in striatum were observed 7 days after the infusion. Co-infusion of carboxyfullerene prevented iron-induced oxidative injury. Furthermore, tyrosine hydroxylase-immunoreactive staining showed that carboxyfullerene inhibited the iron-induced loss of the dopaminergic nerve terminals in striatum. The antioxidative action of carboxyfullerene was verified by in vitro studies. Incubation of brain homogenates increased the formation of the Schiff base fluorescent products of malonaldehyde, an indicator of lipid peroxidation. Both autooxidation (without exogenous iron) and iron-induced elevation of lipid peroxidation of brain homogenates were suppressed by carboxyfullerene in a dose-dependent manner. Our results suggest that intranigral infusion of carboxyfullerene appears to be nontoxic to the nigrostriatal dopaminergic system. Furthermore, the potent antioxidative action of carboxyfullerene protects the nigrostriatal dopaminergic system from iron-induced oxidative injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098871     DOI: 10.1046/j.1471-4159.1999.721634.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Molecular dynamics analysis of a buckyball-antibody complex.

Authors:  William H Noon; Yifei Kong; Jianpeng Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

2.  Inhibition of group A streptococcus infection by carboxyfullerene.

Authors:  N Tsao; T Y Luh; C K Chou; J J Wu; Y S Lin; H Y Lei
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.

Authors:  Qihai Liu; Quanjun Cui; Xudong Joshua Li; Li Jin
Journal:  Connect Tissue Res       Date:  2014-01-24       Impact factor: 3.417

4.  Inhibition of Escherichia coli-induced meningitis by carboxyfullerence.

Authors:  N Tsao; P P Kanakamma; T Y Luh; C K Chou; H Y Lei
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60).

Authors:  B C Braden; F A Goldbaum; B X Chen; A N Kirschner; S R Wilson; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

6.  Scavenging of reactive oxygen and nitrogen species with nanomaterials.

Authors:  Carolina A Ferreira; Dalong Ni; Zachary T Rosenkrans; Weibo Cai
Journal:  Nano Res       Date:  2018-05-26       Impact factor: 8.897

7.  Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.

Authors:  Alexandre S Basso; Dan Frenkel; Francisco J Quintana; Frederico A Costa-Pinto; Sanja Petrovic-Stojkovic; Lindsay Puckett; Alon Monsonego; Amnon Bar-Shir; Yoni Engel; Michael Gozin; Howard L Weiner
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 8.  Biomedical applications of functionalized fullerene-based nanomaterials.

Authors:  Ranga Partha; Jodie L Conyers
Journal:  Int J Nanomedicine       Date:  2009

Review 9.  Nanotechnology-novel therapeutics for CNS disorders.

Authors:  Maya Srikanth; John A Kessler
Journal:  Nat Rev Neurol       Date:  2012-04-24       Impact factor: 42.937

Review 10.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.